Aptose Biosciences (APTO) Misses Q1 EPS by 4c

Aptose Biosciences (NASDAQ: APTO) reported Q1 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss